APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pets Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pets Anti-infective Drugs Market Outlook and Growth Opportunities 2026

29 December 2025193 pages

Choose your research edition.

Industry ResearchPets Anti-infective Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pets Anti-infective Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pets Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pets Anti-infective Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pets Anti-infective Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pets Anti-infective Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pets Anti-infective Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pets Anti-infective Drugs market include Bimeda Animal Health, Ceva Santé Animale, Dechra Veterinary Products, Elanco, Norbrook, Ouro Fino Saude, Vetoquinol, Virbac and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pets Anti-infective Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pets Anti-infective Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pets Anti-infective Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pets Anti-infective Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pets Anti-infective Drugs Segment by Company

Bimeda Animal Health

Ceva Santé Animale

Dechra Veterinary Products

Elanco

Norbrook

Ouro Fino Saude

Vetoquinol

Virbac

Zoetis

Zhejiang Hisun Animal Healthcare Products

Hanvet Pet Health

Wuhan Hvsen Biotechnology

Nanjing Jindun Animal

Merck

Wuhan Chopperlvya

Pets Anti-infective Drugs Segment by Type

Injection

External Use

Internal Use

Pets Anti-infective Drugs Segment by Application

Dog

Cat

Others

Pets Anti-infective Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pets Anti-infective Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pets Anti-infective Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pets Anti-infective Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Pets Anti-infective Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pets Anti-infective Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pets Anti-infective Drugs industry.

Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pets Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pets Anti-infective Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pets Anti-infective Drugs Industry Trends Table 2. Pets Anti-infective Drugs Industry Drivers Table 3. Pets Anti-infective Drugs Industry Opportunities and Challenges Table 4. Pets Anti-infective Drugs Industry Restraints Table 5. Global Pets Anti-infective Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pets Anti-infective Drugs Revenue Share by Company (2021-2026) Table 7. Global Pets Anti-infective Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pets Anti-infective Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Pets Anti-infective Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pets Anti-infective Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pets Anti-infective Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Pets Anti-infective Drugs Company, Product Type & Application Table 13. Global Pets Anti-infective Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pets Anti-infective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of External Use Table 19. Significant Companies of Internal Use Table 20. Global Pets Anti-infective Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pets Anti-infective Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Pets Anti-infective Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Pets Anti-infective Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Pets Anti-infective Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Pets Anti-infective Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pets Anti-infective Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Pets Anti-infective Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Pets Anti-infective Drugs Sales Value Share by Type (2021-2026) Table 29. Global Pets Anti-infective Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dog Table 31. Significant Companies of Cat Table 32. Significant Companies of Others Table 33. Global Pets Anti-infective Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pets Anti-infective Drugs Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Pets Anti-infective Drugs Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Pets Anti-infective Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Pets Anti-infective Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Pets Anti-infective Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pets Anti-infective Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pets Anti-infective Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pets Anti-infective Drugs Sales Value Share by Application (2021-2026) Table 42. Global Pets Anti-infective Drugs Sales Value Share by Application (2027-2032) Table 43. Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pets Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Pets Anti-infective Drugs Sales Market Share by Region (2021-2026) Table 46. Global Pets Anti-infective Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Pets Anti-infective Drugs Sales Market Share by Region (2027-2032) Table 48. Global Pets Anti-infective Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pets Anti-infective Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pets Anti-infective Drugs Sales Value Share by Region (2021-2026) Table 51. Global Pets Anti-infective Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pets Anti-infective Drugs Sales Value Share by Region (2027-2032) Table 53. Global Pets Anti-infective Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Pets Anti-infective Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Pets Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Pets Anti-infective Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 58. Global Pets Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 59. Global Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Pets Anti-infective Drugs Sales Market Share by Country (2027-2032) Table 61. Global Pets Anti-infective Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pets Anti-infective Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Pets Anti-infective Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pets Anti-infective Drugs Sales Value Market Share by Country (2027-2032) Table 65. Bimeda Animal Health Company Information Table 66. Bimeda Animal Health Business Overview Table 67. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio Table 69. Bimeda Animal Health Recent Development Table 70. Ceva Santé Animale Company Information Table 71. Ceva Santé Animale Business Overview Table 72. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio Table 74. Ceva Santé Animale Recent Development Table 75. Dechra Veterinary Products Company Information Table 76. Dechra Veterinary Products Business Overview Table 77. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio Table 79. Dechra Veterinary Products Recent Development Table 80. Elanco Company Information Table 81. Elanco Business Overview Table 82. Elanco Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Elanco Pets Anti-infective Drugs Product Portfolio Table 84. Elanco Recent Development Table 85. Norbrook Company Information Table 86. Norbrook Business Overview Table 87. Norbrook Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Norbrook Pets Anti-infective Drugs Product Portfolio Table 89. Norbrook Recent Development Table 90. Ouro Fino Saude Company Information Table 91. Ouro Fino Saude Business Overview Table 92. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio Table 94. Ouro Fino Saude Recent Development Table 95. Vetoquinol Company Information Table 96. Vetoquinol Business Overview Table 97. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Vetoquinol Pets Anti-infective Drugs Product Portfolio Table 99. Vetoquinol Recent Development Table 100. Virbac Company Information Table 101. Virbac Business Overview Table 102. Virbac Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Virbac Pets Anti-infective Drugs Product Portfolio Table 104. Virbac Recent Development Table 105. Zoetis Company Information Table 106. Zoetis Business Overview Table 107. Zoetis Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Zoetis Pets Anti-infective Drugs Product Portfolio Table 109. Zoetis Recent Development Table 110. Zhejiang Hisun Animal Healthcare Products Company Information Table 111. Zhejiang Hisun Animal Healthcare Products Business Overview Table 112. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio Table 114. Zhejiang Hisun Animal Healthcare Products Recent Development Table 115. Hanvet Pet Health Company Information Table 116. Hanvet Pet Health Business Overview Table 117. Hanvet Pet Health Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio Table 119. Hanvet Pet Health Recent Development Table 120. Wuhan Hvsen Biotechnology Company Information Table 121. Wuhan Hvsen Biotechnology Business Overview Table 122. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio Table 124. Wuhan Hvsen Biotechnology Recent Development Table 125. Nanjing Jindun Animal Company Information Table 126. Nanjing Jindun Animal Business Overview Table 127. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio Table 129. Nanjing Jindun Animal Recent Development Table 130. Merck Company Information Table 131. Merck Business Overview Table 132. Merck Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Merck Pets Anti-infective Drugs Product Portfolio Table 134. Merck Recent Development Table 135. Wuhan Chopperlvya Company Information Table 136. Wuhan Chopperlvya Business Overview Table 137. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio Table 139. Wuhan Chopperlvya Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Pets Anti-infective Drugs Distributors List Table 143. Pets Anti-infective Drugs Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Pets Anti-infective Drugs Product Image Figure 2. Global Pets Anti-infective Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pets Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pets Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 5. Global Pets Anti-infective Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pets Anti-infective Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. External Use Image Figure 11. Internal Use Image Figure 12. Global Pets Anti-infective Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Pets Anti-infective Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Pets Anti-infective Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Pets Anti-infective Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pets Anti-infective Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pets Anti-infective Drugs Sales Value Share by Type (2021-2032) Figure 18. Dog Image Figure 19. Cat Image Figure 20. Others Image Figure 21. Global Pets Anti-infective Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pets Anti-infective Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pets Anti-infective Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Pets Anti-infective Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pets Anti-infective Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pets Anti-infective Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Pets Anti-infective Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pets Anti-infective Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pets Anti-infective Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pets Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pets Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pets Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pets Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pets Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pets Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pets Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pets Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pets Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pets Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pets Anti-infective Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pets Anti-infective Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • External Use
  • Internal Use
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Bimeda Animal Health
  • Ceva Santé Animale
  • Dechra Veterinary Products
  • Elanco
  • Norbrook
  • Ouro Fino Saude
  • Vetoquinol
  • Virbac
  • Zoetis
  • Zhejiang Hisun Animal Healthcare Products
  • Hanvet Pet Health
  • Wuhan Hvsen Biotechnology
  • Nanjing Jindun Animal
  • Merck
  • Wuhan Chopperlvya

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pets Anti-infective Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Pets Anti-infective Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Pets Anti-infective Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pets Anti-infective Drugs Market Dynamics
  1. 2.1 Pets Anti-infective Drugs Industry Trends
  2. 2.2 Pets Anti-infective Drugs Industry Drivers
  3. 2.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Pets Anti-infective Drugs Industry Restraints
3 Pets Anti-infective Drugs Market by Company
  1. 3.1 Global Pets Anti-infective Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Pets Anti-infective Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Pets Anti-infective Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Pets Anti-infective Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Pets Anti-infective Drugs Company Ranking (2024-2026)
  6. 3.6 Global Pets Anti-infective Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Pets Anti-infective Drugs Company Product Type and Application
  8. 3.8 Global Pets Anti-infective Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pets Anti-infective Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pets Anti-infective Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pets Anti-infective Drugs Market by Type
  1. 4.1 Pets Anti-infective Drugs Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 External Use
  4. 4.1.3 Internal Use
  5. 4.2 Global Pets Anti-infective Drugs Sales Volume by Type
  6. 4.2.1 Global Pets Anti-infective Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pets Anti-infective Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Pets Anti-infective Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Pets Anti-infective Drugs Sales Value by Type
  10. 4.3.1 Global Pets Anti-infective Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pets Anti-infective Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Pets Anti-infective Drugs Sales Value Share by Type (2021-2032)
5 Pets Anti-infective Drugs Market by Application
  1. 5.1 Pets Anti-infective Drugs Application Introduction
  2. 5.1.1 Dog
  3. 5.1.2 Cat
  4. 5.1.3 Others
  5. 5.2 Global Pets Anti-infective Drugs Sales Volume by Application
  6. 5.2.1 Global Pets Anti-infective Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pets Anti-infective Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pets Anti-infective Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pets Anti-infective Drugs Sales Value by Application
  10. 5.3.1 Global Pets Anti-infective Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pets Anti-infective Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pets Anti-infective Drugs Sales Value Share by Application (2021-2032)
6 Pets Anti-infective Drugs Regional Sales and Value Analysis
  1. 6.1 Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pets Anti-infective Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pets Anti-infective Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Pets Anti-infective Drugs Sales by Region (2027-2032)
  5. 6.3 Global Pets Anti-infective Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pets Anti-infective Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pets Anti-infective Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pets Anti-infective Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Pets Anti-infective Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pets Anti-infective Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Pets Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pets Anti-infective Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Pets Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pets Anti-infective Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pets Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pets Anti-infective Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Pets Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pets Anti-infective Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pets Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
7 Pets Anti-infective Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Pets Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pets Anti-infective Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pets Anti-infective Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Pets Anti-infective Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Pets Anti-infective Drugs Sales by Country (2027-2032)
  6. 7.4 Global Pets Anti-infective Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pets Anti-infective Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pets Anti-infective Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pets Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pets Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pets Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bimeda Animal Health
  2. 8.1.1 Bimeda Animal Health Company Information
  3. 8.1.2 Bimeda Animal Health Business Overview
  4. 8.1.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
  6. 8.1.5 Bimeda Animal Health Recent Developments
  7. 8.2 Ceva Santé Animale
  8. 8.2.1 Ceva Santé Animale Company Information
  9. 8.2.2 Ceva Santé Animale Business Overview
  10. 8.2.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
  12. 8.2.5 Ceva Santé Animale Recent Developments
  13. 8.3 Dechra Veterinary Products
  14. 8.3.1 Dechra Veterinary Products Company Information
  15. 8.3.2 Dechra Veterinary Products Business Overview
  16. 8.3.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
  18. 8.3.5 Dechra Veterinary Products Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Pets Anti-infective Drugs Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 Norbrook
  26. 8.5.1 Norbrook Company Information
  27. 8.5.2 Norbrook Business Overview
  28. 8.5.3 Norbrook Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Norbrook Pets Anti-infective Drugs Product Portfolio
  30. 8.5.5 Norbrook Recent Developments
  31. 8.6 Ouro Fino Saude
  32. 8.6.1 Ouro Fino Saude Company Information
  33. 8.6.2 Ouro Fino Saude Business Overview
  34. 8.6.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
  36. 8.6.5 Ouro Fino Saude Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Virbac
  44. 8.8.1 Virbac Company Information
  45. 8.8.2 Virbac Business Overview
  46. 8.8.3 Virbac Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Virbac Pets Anti-infective Drugs Product Portfolio
  48. 8.8.5 Virbac Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Pets Anti-infective Drugs Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 Zhejiang Hisun Animal Healthcare Products
  56. 8.10.1 Zhejiang Hisun Animal Healthcare Products Company Information
  57. 8.10.2 Zhejiang Hisun Animal Healthcare Products Business Overview
  58. 8.10.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio
  60. 8.10.5 Zhejiang Hisun Animal Healthcare Products Recent Developments
  61. 8.11 Hanvet Pet Health
  62. 8.11.1 Hanvet Pet Health Company Information
  63. 8.11.2 Hanvet Pet Health Business Overview
  64. 8.11.3 Hanvet Pet Health Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio
  66. 8.11.5 Hanvet Pet Health Recent Developments
  67. 8.12 Wuhan Hvsen Biotechnology
  68. 8.12.1 Wuhan Hvsen Biotechnology Company Information
  69. 8.12.2 Wuhan Hvsen Biotechnology Business Overview
  70. 8.12.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio
  72. 8.12.5 Wuhan Hvsen Biotechnology Recent Developments
  73. 8.13 Nanjing Jindun Animal
  74. 8.13.1 Nanjing Jindun Animal Company Information
  75. 8.13.2 Nanjing Jindun Animal Business Overview
  76. 8.13.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
  78. 8.13.5 Nanjing Jindun Animal Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Merck Pets Anti-infective Drugs Product Portfolio
  84. 8.14.5 Merck Recent Developments
  85. 8.15 Wuhan Chopperlvya
  86. 8.15.1 Wuhan Chopperlvya Company Information
  87. 8.15.2 Wuhan Chopperlvya Business Overview
  88. 8.15.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
  90. 8.15.5 Wuhan Chopperlvya Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pets Anti-infective Drugs Value Chain Analysis
  2. 9.1.1 Pets Anti-infective Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pets Anti-infective Drugs Sales Mode & Process
  6. 9.2 Pets Anti-infective Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pets Anti-infective Drugs Distributors
  9. 9.2.3 Pets Anti-infective Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst